Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.

Maria Brinkmeier-TheofanopoulouPanagiotis TzamalisSusan Wehrkamp-RichterAndrea RadzewitzMatthias MerkelGerhard SchymikGesine van MarkArmin LuikClaus SchmittArmin Luik

Published in: BMC cardiovascular disorders (2018)

Our dataset illustrates that uninterrupted VKA and DOAC have a better risk-benefit profile than VKA bridging. Bridging was associated with a 4.5× increased risk of complications and should be avoided, if possible.

Keyphrases

catheter ablation
left atrial
atrial fibrillation
direct oral anticoagulants
venous thromboembolism
heart failure
percutaneous coronary intervention
risk factors
mitral valve
coronary artery disease